Working Towards a Better Understanding of Parkinson’s Disease

A detailed and uniform characterization of large patient cohorts is essential for generating therapeutically relevant knowledge about rare diseases.

Detailed characterization of large patient cohorts in a uniform manner is critical for gaining therapeutically relevant insights into rare diseases. CENTOGENE is a major stakeholder in the LIPAD Study, a pertinent project focused on Parkinson’s disease cohorts. The concept and the goals of this study were recently described in a publication in Frontiers in Neurology.

Read publication